Claim open
US MDL, E.D. Pa., Case No. 2:16-md-02724
Marketplace opportunity
Generic Pharmaceuticals Pricing Antitrust End-Payer Settlements, including Sun/Taro and Sandoz
Consumers and third-party payers who indirectly purchased, paid for, or reimbursed named generic drugs in eligible U.S. jurisdictions from 2009-05-01 through 2019-12-31 may qualify, subject to listed exclusions.
- Claim window
- Claim deadline: 2026-11-09T00:00:00.000Z
- Claim instructions and claim form deadline.
- Estimated payout
- Pro rata share; Sun/Taro fund $200M and broader current EPP settlements reported around $533M.
- Pro rata share; Sun/Taro fund $200M and broader current EPP settlements reported around $533M.
Eligibility
Official sources
- Official sourceSource kind: officialSource last checked: not recorded
Verification note
Official claim instructions and claim form state November 9, 2026 deadline and proof requirements. Founder-approved for public catalog via app-compens-ai-approval-9013ac9c.
This is informational routing only, not legal advice, not a guarantee of eligibility or payout, and not an automatic submission on your behalf. Compens.ai does not represent you in this matter. Always confirm current details directly with the official source or claims administrator linked above before acting.